Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

Market Cap	10.57B
Revenue (ttm)	1.67B
Net Income (ttm)	333.58M
Shares Out	411.64M
EPS (ttm)	0.81
PE Ratio	31.67
Forward PE	26.74
Dividend	0.80 (3.07%)
Ex-Dividend Date	Jun 10, 2025

Volume	3,016,623
Average Volume	1,774,540
Open	25.94
Previous Close	25.94
Day's Range	25.92 - 26.14
52-Week Range	21.95 - 33.15
Beta	0.71
RSI	51.81
Earnings Date	Aug 29, 2025

About SHA:688739

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,732
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688739

Financial Performance

In 2024, SHA:688739's revenue was 1.68 billion, a decrease of -4.22% compared to the previous year's 1.75 billion. Earnings were 342.82 million, a decrease of -26.42%.